CC BY
6
UDC 618.36:616.379-008.64
Вестник СПбГУ Медицина. 2019. Т. 14. Вып. 4
NK-cells in placenta of female patients with type 1 diabetes mellitus
A. O. Drobintseva1,2, D. S. Medvedev2,3, I. D. Yushkova2, V. O. Polyakova1,2
1 St. Petersburg State Pediatric Medical University,
2, Litovskaya ul., St. Petersburg, 194100, Russian Federation
2 St. Petersburg Medico-Social Institute,
72, Kondrat'evskii pr., St. Petersburg, 195271, Russian Federation
3 St. Petersburg Institute of Bioregulation and Gerontology,
3, pr. Dinamo, St. Petersburg, 197110, Russian Federation
For citation: Drobintseva A. O., Medvedev D. S., Yushkova I. D., Polyakova V. O. NK-cells in placenta of female patients with type 1 diabetes mellitus. Vestnik of Saint Petersburg University. Medicine, 2019, vol. 14, issue 4, pp. 367-371. https://doi.org/10.21638/spbu11.2019.429
Placenta is a temporary organ that performs multiple functions to provide a normal course of the intrauterine development of the child. However, immune interactions in placenta are not well understood. Since women with type 1 diabetes mellitus have a greater risk of adverse pregnancy outcomes due to aberrant immunological adaptation, the study of immunological interactions in placenta of these women is of particular interest. In this study a comparative analysis of the age-related expression parameters of marker of NK-cells (CD57) in placenta in patients with type 1 diabetes mellitus was performed. The current study revealed differences in the expression parameters of NK-cells marker between two age subgroups of the patients and compared to healthy controls. The results indicate the high significance of inflammatory markers in women with type 1 diabetes mellitus for assessing the course of pregnancy and the possible development of somatic pathology in newborns, especially from older women.
Keywords: type 1 diabetes mellitus, T1DM, pregnancy, NK-cells, autoimmunity in pregnancy.
Introduction
Placenta is a temporary organ that connects a developing fetus through the umbilical cord with uterine and provides assimilation of nutrients and oxygen, thermoregulation, and removal of metabolic products through maternal bloodstream. Moreover, placenta produces a number of hormones that affect the pregnancy course. However, many issues related to the placental barrier, in particular, immune interactions, remain unknown.
According to the recent data, pregnancy in women with type 1 diabetes mellitus (T1DM) is associated with risks of premature birth, preeclampsia, macrosomia, fetal death, heart and kidney malformations, however, glycemic control and pregravid preparation can reduce the frequency of fetal death and malformations [1].
Different phases of pregnancy are pro- and anti-inflammatory [2]. Thus, the phase of rapid fetal growth and development is anti-inflammatory, while the phases of implantation and childbirth are pro-inflammatory. Currently, it is known that tolerance of the maternal organism to the fetus is caused by modulation of the immune system [3]. Since
© Санкт-Петербургский государственный университет, 2020
https://doi.org/10.21638/spbu11.2019.429
367
women with T1DM have a greater risk of adverse pregnancy outcomes due to aberrant immunological adaptation (such as changes in the number of leukocytes, the increased ratio of Th1/Th2, increased expression of CD335 in NK-cells, enhanced activation of intermediate and non-classical monocytes [4]), the study of immunological interactions in placenta of women with T1DM is of particular interest.
The aim of our study was a comparative analysis of the age-related expression parameters of marker of NK-cells (CD57) in placenta in patients with T1DM. The villous chorion was the object of the study, since, due to the structural features, it plays the most important role in the implementation of metabolic processes between maternal and fetal bloodstreams.
Materials and methods
The samples of 80 placentas at 36-40 gestation weeks were chosen for our study. All samples were obtained at the Maternity department of the D. O. Ott Research Institute of Obstetrics, Gynecology and Reproductology (St. Petersburg, Russia) from primiparous and multiparous women aged from 19 to 40 years. For control group the samples from women without T1DM, T2DM and gestational diabetes were obtained. According to previous studies, in pregnant women who are over 28 y. o., in most cases, involutive and dystrophic changes in placenta are observed [5]. In this regard, the samples were divided into groups (table) from 19 to 28 y. o. (inclusive) and older than 28 y. o. to 40 y. o. (inclusive).
Table. Information about groups dividing
Group Mean age, years Number of samples Designation
Control Primiparous < 28 23.6 ± 1.39 n = 10 CPY
Primiparous > 28 34.0 ± 2.42 n = 10 CPO
Multiparous < 28 24.11 ± 1.73 n = 10 CMY
Multiparous > 28 35.3 ± 3.15 n = 10 CMO
T1DM Primiparous < 28 24.67 ± 0.97 n = 10 DPY
Primiparous > 28 33.0 ± 2.03 n = 10 DPO
Multiparous < 28 25.48 ± 1.83 n = 10 DMY
Multiparous > 28 35.23 ± 1.67 n = 10 DMO
The histological sections were prepared according to the standard protocol for FFPE tissues. For immunohistochemical staining, sections were placed on glass slides coated with a film of poly-L-lysine (Sigma). CD57 (1:50, Novocastra) primary monoclonal antibodies were used. A universal kit containing biotinylated secondary antibodies was used (ABC-kit, Novocastra). Morphometric analysis was performed using "VideoTest Mor-phologia 5.0" software. In each case, 5 fields of view were analyzed at a magnification of 400. The relative area (RA) and the optical density (OD) of expression were taken as the estimated parameters. These parameters reflect the intensity of synthesis or accumulation of the signal molecules. Statistical analysis was carried out using Statistica 6.0.
368
Вестник CnôrY Медицина. 2019. T. 14. Bun. 4
=■28 years
Fig. The relative area and the optical density of CD57 expression in placentas
Results
In all cases the delivery occurred at a gestational age of 37-40 weeks. The body weight of newborns in women in the control group was from 3040 to 3880 g (mean weight 3488 ± 126 g), in the T1DM group — from 3180 to 4300 g (mean weight 3690 ± 260 g). According to the mass and height parameters of newborns, no significant differences were found. The lowest Apgar score in the groups studies (6 points) was observed in the subgroup of older women in the T1DM group. In addition, postpartum jaundice was detected in 35 % of newborns of mothers with T1DM. The expression of the NK-cells marker in the chorionic villi was weak in all studied groups. However, from the data obtained, it can be concluded that NK-cells are present in the placentas of women with T1DM in a greater amount than in control group. In the subgroups of multiparous women, a decrease in the RA of CD57 was found in the subgroup of older reproductive age compared with the younger one in T1DM group (figure).
Conclusion
The current study revealed differences in the expression parameters of NK-cells marker between patients with T1DM and healthy patients. The signaling molecules and cytokines produced by immune cells play a key role in the development of pathological conditions that occur during pregnancy. Our study confirms the presence of ongo-
Вестник СПбГУ. Медицина. 2019. Т. 14. Вып. 4
369
ing changes in the uterus-placenta system in T1DM patients. In our previous study we showed that NK-cells as well as cytotoxic T-cells has a great impact in development of gestosis [6], and women with T1DM have a significant greater incidence of gestosis than a control group. The results of the current study indicate the high epidemiological and research significance of inflammatory markers for assessing the course of pregnancy and the possible development of somatic pathology in newborns, especially from older women.
References
1. Feldman A. Z., Brown F. M. Management of type 1 diabetes in pregnancy. Curr. Diab. Rep., 2016, vol. 16, no. 76. https://doi.org/10.1007/s11892-016-0765-z.
2. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol., 2010, vol. 63, no. 6, pp. 425-433. https://doi.org/10.1111/j.1600-0897.2010.00836.x.
3. Tabarkiewicz J., Selvan S. R., Cools N. J. Autoimmunity in reproductive health and pregnancy. Immunol. Res., 2018. 9501865.
4. Groen B., van der Wijk A. E., van den Berg P. P., Lefrandt J. D., van den Berg G., Sollie K. M., de Vos P., Links T. P., Faas M. M. Immunological adaptations to pregnancy in women with type 1 diabetes. Sci. Rep., 2015, Sep 22; 5: 13618. https://doi.org/10.1038/srep13618.
5. Aylamazyan E. K. Obstetrics. Textbook for Medical Universities. St. Petersburg, SpezLit Publ., 2003. (In Russian)
6. Ailamazyan E. K., Polyakova V. O., Linkova N. S., Kvetnoy I. M., Durnova A. O. The role of resident immune cells in the development of the placenta is normal and in pathology. Zhurnal akusherstva i zhenskikh boleznei, 2010, vol. 59, no. 6, pp. 8-14. (In Russian)
Received: February 12, 2020 Accepted: May 25, 2020
Authors' information:
Anna O. Drobintseva — PhD, Associate Professor; anna.drobintseva@gmail.com Irina D. Yushkova — PhD; irusik-m@list.ru
Dmitriy S. Medvedev — PhD, MD, Professor; 79110982285@yandex.ru Victoria O. Polyakova — PhD, Professor; vopol@yandex.ru
370
Вестник СПбГУ. Медицина. 2019. Т. 14. Вып. 4
